全文获取类型
收费全文 | 4805篇 |
免费 | 220篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 70篇 |
妇产科学 | 72篇 |
基础医学 | 701篇 |
口腔科学 | 156篇 |
临床医学 | 285篇 |
内科学 | 1051篇 |
皮肤病学 | 55篇 |
神经病学 | 381篇 |
特种医学 | 160篇 |
外国民族医学 | 1篇 |
外科学 | 925篇 |
综合类 | 15篇 |
预防医学 | 130篇 |
眼科学 | 83篇 |
药学 | 453篇 |
中国医学 | 10篇 |
肿瘤学 | 476篇 |
出版年
2023年 | 29篇 |
2022年 | 56篇 |
2021年 | 98篇 |
2020年 | 57篇 |
2019年 | 56篇 |
2018年 | 90篇 |
2017年 | 90篇 |
2016年 | 93篇 |
2015年 | 85篇 |
2014年 | 115篇 |
2013年 | 163篇 |
2012年 | 245篇 |
2011年 | 267篇 |
2010年 | 141篇 |
2009年 | 144篇 |
2008年 | 238篇 |
2007年 | 238篇 |
2006年 | 236篇 |
2005年 | 223篇 |
2004年 | 193篇 |
2003年 | 180篇 |
2002年 | 197篇 |
2001年 | 145篇 |
2000年 | 173篇 |
1999年 | 167篇 |
1998年 | 73篇 |
1997年 | 52篇 |
1996年 | 56篇 |
1995年 | 40篇 |
1994年 | 36篇 |
1993年 | 30篇 |
1992年 | 108篇 |
1991年 | 91篇 |
1990年 | 113篇 |
1989年 | 114篇 |
1988年 | 86篇 |
1987年 | 77篇 |
1986年 | 60篇 |
1985年 | 67篇 |
1984年 | 54篇 |
1983年 | 40篇 |
1982年 | 19篇 |
1980年 | 14篇 |
1979年 | 21篇 |
1977年 | 16篇 |
1973年 | 17篇 |
1972年 | 18篇 |
1970年 | 16篇 |
1969年 | 13篇 |
1968年 | 17篇 |
排序方式: 共有5049条查询结果,搜索用时 12 毫秒
101.
102.
Ohmori T Yatomi Y Osada M Kazama F Takafuta T Ikeda H Ozaki Y 《Cardiovascular research》2003,58(1):170-177
OBJECTIVES: Sphingosine 1-phosphate (Sph-1-P), a bioactive lipid derived from activated platelets, may play an important role in coronary artery spasm and hence the pathogenesis of ischemic heart diseases, since we reported that a decrease in coronary blood flow was induced by this lysophospholipid in an in vivo canine heart model [Cardiovasc. Res. 46 (2000) 119]. In this study, metabolism related to and cellular responses elicited by Sph-1-P were examined in human coronary artery smooth muscle cells (CASMCs). METHODS AND RESULTS: [3H]Sphingosine (Sph), incorporated into CASMCs, was converted to [3H]Sph-1-P intracellularly, but its stimulation-dependent formation and extracellular release were not observed. Furthermore, the cell surface Sph-1-P receptors of S1P family (previously called EDG) were found to be expressed in CASMCs. Accordingly, Sph-1-P seems to act as an extracellular mediator in CASMCs. Consistent with Sph-1-P-elicited coronary vasoconstriction in vivo, Sph-1-P strongly induced CASMC contraction, which was inhibited by JTE-013, a newly-developed specific antagonist of S1P(2) (EDG-5). Furthermore, C3 exoenzyme or Y-27632 inhibited the CASMC contraction induced by Sph-1-P, indicating Rho involvement. Finally, exogenously-added [3H]Sph-1-P underwent a rapid degradation. Since lipid phosphate phosphatases, ectoenzymes capable of dephosphorylating Sph-1-P, were expressed in CASMCs, Sph-1-P may be dephosphorylated by the ectophosphatases. CONCLUSIONS: Sph-1-P, derived from platelets and dephosphorylated on the cell surface, may induce the contraction of coronary artery smooth muscle cells through the S1P(2)/Rho signaling. 相似文献
103.
104.
105.
106.
107.
108.
109.
Mutsumi Araki Misaho Kitayoshi Yan Dong Miku Hirane Shuhei Ozaki Shiori Mori 《Growth factors (Chur, Switzerland)》2014,32(3-4):117-122
AbstractLysophosphatidic acid (LPA) is a bioactive lipid that interacts with G protein-coupled LPA receptors (LPA receptor-1 (LPA1) to LPA6). Here, we investigated the effects of LPA signaling via LPA5 on cellular functions of sarcoma cells by generating Lpar5 overexpressing and Lpar5 knockdown cells from rat osteosarcoma and malignant fibrous histiocytoma cells, respectively. The cell motility activity of Lpar5 overexpressing cells was significantly lower, while Lpar5 knockdown cells showed high cell motility, compared with respective controls. Gelatin zymography showed that LPA5 suppressed the activation of matrix metalloproteinase-2. LPA5 also inhibited the cell motility activity of endothelial cells, correlating with the expression levels of vascular endothelial growth factor genes. These results suggest that LPA signaling via LPA5 negatively regulates the cellular functions of rat sarcoma cells. 相似文献
110.
Hiroshi Morimoto Hironori Shimada Kenichi Ozaki 《International journal of behavioral medicine》2014,21(3):447-455